Volume 27, Issue 7 (12-2019)                   JSSU 2019, 27(7): 1724-1734 | Back to browse issues page

XML Persian Abstract Print

Abstract:   (1199 Views)
Introduction: The emergence and spread of the pandemic H1N1 influenza virus in 2009 indicates a limitation in the strategy to control the infection, despite a long-established vaccination programme and approved antivirals. Production the proper vaccine against influenza is difficult due to the genetic recombination of virus in the event of pandemic and co-circulation of drug-resistance variants highlights the need for the development of new effective and broad-spectrum influenza therapies. Currently, the investigations lie on viral attachment and entry inhibitors, and more attention focuses on viral genome replication and transcription inhibitors in such a way that selective pressure applied by the use of antiviral drugs has covered against all strains. In this review, the novel antiviral agents that targeted the virus-cell membrane attachment, and transcription of the viral genome are discussed
Full-Text [PDF 340 kb]   (361 Downloads)    
Type of Study: Review article | Subject: Pharmacology
Received: 2019/02/20 | Accepted: 2019/08/10 | Published: 2019/12/3